Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-1596
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect? ; volume:7 ; number:1 ; day:6 ; month:7 ; year:2012 ; pages:1-3 ; date:12.2012
Diagnostic pathology ; 7, Heft 1 (6.7.2012), 1-3, 12.2012
- Creator
-
Petcu, Eugen B.
- Contributor
-
Ivanovski, Saso
Wright, Robert G.
Slevin, Mark
Miroiu, Rodica I.
Brinzaniuc, Klara
SpringerLink (Online service)
- DOI
-
10.1186/1746-1596-7-78
- URN
-
urn:nbn:de:1111-2016080741771
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Petcu, Eugen B.
- Ivanovski, Saso
- Wright, Robert G.
- Slevin, Mark
- Miroiu, Rodica I.
- Brinzaniuc, Klara
- SpringerLink (Online service)
Other Objects (12)
Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect
Perceptions of medical doctors on bisphosphonate-related osteonecrosis of the jaw
Bisphosphonate-Related Osteonecrosis of the Jaw: An Enigma among Medical Practitioners
Significance of medication discontinuation on bisphosphonate-related jaw osteonecrosis in a rat model
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
Characterization of Mesenchymal Stem Cells Derived from Bisphosphonate-Related Osteonecrosis of the Jaw Patients’ Gingiva
Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw
Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report
Anti-angiogenic therapies in brain metastases
Anti-angiogenic alternatives to VEGF blockade
Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect
Perceptions of medical doctors on bisphosphonate-related osteonecrosis of the jaw
Bisphosphonate-Related Osteonecrosis of the Jaw: An Enigma among Medical Practitioners
Significance of medication discontinuation on bisphosphonate-related jaw osteonecrosis in a rat model
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
Characterization of Mesenchymal Stem Cells Derived from Bisphosphonate-Related Osteonecrosis of the Jaw Patients’ Gingiva
Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw
Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report
Anti-angiogenic therapies in brain metastases
Anti-angiogenic alternatives to VEGF blockade
Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect
Perceptions of medical doctors on bisphosphonate-related osteonecrosis of the jaw
Bisphosphonate-Related Osteonecrosis of the Jaw: An Enigma among Medical Practitioners
Significance of medication discontinuation on bisphosphonate-related jaw osteonecrosis in a rat model
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
Characterization of Mesenchymal Stem Cells Derived from Bisphosphonate-Related Osteonecrosis of the Jaw Patients’ Gingiva
Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw
Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report
Anti-angiogenic therapies in brain metastases